Cobra Venom Factor Boosts Arteriogenesis in Mice
Authors:
- Philipp GötzPGPhilipp Götz
- Sharon O. Azubuike-OsuSharon O. Azubuike-Osu
- Anna BraumandlABAnna Braumandl
- Christoph ArnholdtCAChristoph Arnholdt
- Matthias KüblerMKMatthias Kübler
- Lisa RichterLRLisa Richter
- Manuel LaschMLManuel Lasch
- Lisa BobrowskiLBLisa Bobrowski
- Klaus T. PreissnerKlaus T. Preissner
- Elisabeth DeindlElisabeth Deindl
Open Access
- 30 July 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (15) , 8454
Abstract
Arteriogenesis, the growth of natural bypass blood vessels, can compensate for the loss of arteries caused by vascular occlusive diseases. Accordingly, it is a major goal to identify the drugs promoting this innate immune system-driven process in patients aiming to save their tissues and life. Here, we studied the impact of the Cobra venom factor (CVF), which is a C3-like complement-activating protein that induces depletion of the complement in the circulation in a murine hind limb model of arteriogenesis. Arteriogenesis was induced in C57BL/6J mice by femoral artery ligation (FAL). The administration of a single dose of CVF (12.5 µg) 24 h prior to FAL significantly enhanced the perfusion recovery 7 days after FAL, as shown by Laser Doppler imaging. Immunofluorescence analyses demonstrated an elevated number of proliferating (BrdU+) vascular cells, along with an increased luminal diameter of the grown collateral vessels. Flow cytometric analyses of the blood samples isolated 3 h after FAL revealed an elevated number of neutrophils and platelet-neutrophil aggregates. Giemsa stains displayed augmented mast cell recruitment and activation in the perivascular space of the growing collaterals 8 h after FAL. Seven days after FAL, we found more CD68+/MRC-1+ M2-like polarized pro-arteriogenic macrophages around growing collaterals. These data indicate that a single dose of CVF boosts arteriogenesis by catalyzing the innate immune reactions, relevant for collateral vessel growth.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG DE 685/6-1)
- Ludwig-Maximilians-Universität (DFG DE 685/6-1)
This publication has 57 references indexed in Scilit:
- Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-ThrombosisPLOS ONE, 2013
- The Temporal and Spatial Distribution of Macrophage Subpopulations During ArteriogenesisCurrent Vascular Pharmacology, 2013
- The collateral network concept: Remodeling of the arterial collateral network after experimental segmental artery sacrificeThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesisBlood, 2010
- Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemiaNature Protocols, 2009
- The alternative pathway of complement in disease: opportunities for therapeutic targetingMolecular Immunology, 2004
- Receptor‐independent role of the urokinase‐type plasminogen activator during arteriogenesisThe FASEB Journal, 2003
- ComplementNew England Journal of Medicine, 2001
- Activation of human neutrophils by C3a and C5A Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burstFEBS Letters, 1994
- New biological activity following intravascular activation of the complement cascadeNature, 1974